Todd Shegog

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd Shegog:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Director Stock Option (Right to Buy) 44,700 04 Jun 2025 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Financial Officer Common Stock 0 $5.05 14 Oct 2022 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Financial Officer Stock Option (Right to Buy) 0 14 Oct 2022 Direct

Insider Reports Filed by Todd Shegog

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COGT Cogent Biosciences, Inc. 04 Jun 2025 1 $0 4 Director 05 Jun 2025, 16:21
COGT Cogent Biosciences, Inc. 05 Jun 2024 1 $0 4 Director 13 Jun 2024, 19:07
COGT Cogent Biosciences, Inc. 07 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:43
/report/000089924322033651-shegog-todd-2022-10-14 Forma Therapeutics Holdings, Inc. 14 Oct 2022 7 $0 4 SVP, Chief Financial Officer 14 Oct 2022, 16:06
COGT Cogent Biosciences, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 17:07
/report/000089924322008636-shegog-todd-2022-02-28 Forma Therapeutics Holdings, Inc. 28 Feb 2022 2 $0 4 SVP, Chief Financial Officer 02 Mar 2022, 16:11
/report/000089924322007913-shegog-todd-2022-02-23 Forma Therapeutics Holdings, Inc. 23 Feb 2022 1 -$55,605 4 SVP, Chief Financial Officer 25 Feb 2022, 16:04